Guggenheim Securities

Dallas’ Forte Biosciences Announces $53M Private Placement From Leading Healthcare Investors

by | Nov 21, 2024
Headquartered at Dallas' Pegasus Park, Forte Biosciences is developing a proprietary molecule with potentially broad autoimmune and autoimmune-related applications.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.